Search results
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 4 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company ...
Penn researchers create avian flu vaccine using COVID shot technique
The Patriot-News· 6 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US By Reuters
Investing.com· 6 days agoThe European Union's regulator told vaccine makers last month to update their vaccines for that...
Arizona researcher publishes study on COVID-19 vaccine and tinnitus
ABC 15 Phoenix· 5 days agoA newly published scientific study about the COVID-19 vaccine found people with certain preexisting medical conditions were more likely to report ringing ...
Pfizer's Path To Profit: A Look At PFE Stock As Drugmaker Rolls Out $1.5B In Cost Reductions - ...
Benzinga· 7 days agoPfizer Inc. PFE has recently launched a multi-year cost reduction initiative aimed at saving...
BioNTech gets $145 million funding for African vaccine plants
Reuters via Yahoo News· 1 day agoFRANKFURT (Reuters) -COVID-19 vaccine maker BioNTech has secured up to $145 million in funding from...
Here's how U.S. health officials are responding to bird flu in humans after second case
CNBC· 6 days agoU.S. health officials are monitoring and preparing to combat bird flu in humans, even as they...
Pfizer Stock: Chart Indicates a Long-Term Bottom , But Is the Dividend Safe? | Investing.com
Investing.com· 3 days agoLooking at the lower third of PFE, you can...revenue spiked to over $100 bl by the end of 2022,...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 7 days agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
How Much Will Pfizer Pay Out in Dividends This Year? | The Motley Fool
The Motley Fool· 4 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (PFE 0.66%) a household name in recent years, but this isn't all the company ...